Grants for Small businesses - Science and Technology

This funding opportunity provides financial support to institutions and organizations for developing and advancing innovative therapies and diagnostic tools in tissue engineering and regenerative medicine, with a focus on preparing these technologies for clinical use.

This grant provides funding and mentorship to early-career scientists and engineers in the U.S. to develop innovative energy technologies that can significantly impact the energy sector.

Grant Opportunity: The Future of America's Alliances Funder: The Charles Koch Foundation Award Details: Funding levels are commensurate with the requirements of the research and the potential for the research to advance an understanding of critical issues. Accepted proposals may also receive support to disseminate the research findings. Eligibility: Organizations of all types across the USA, including nonprofits, startups, researchers, local governments, and small businesses. Other Relevant Information: - Proposals should evaluate areas where U.S. interests converge or diverge from long-established allies and consider challenges in maintaining alliances in different regions. - Projects should study ways to promote burden-sharing and partners' deterrent capabilities. - Research on the long-term future of NATO, unintended consequences of alliances, advantages of different security arrangements, and problems with foreign arms sales is encouraged. - Proposals should assess historical cases of alliance dissolution and explore options for "transatlantic transformation." - A two-to-five page abstract, CV or résumé, and a brief itemized budget are required in the application. - Proposals will be accepted and evaluated on a rolling basis. For more information and to apply, visit: https://charleskochfoundation.tfaforms.net/344037?tfa_13=tfa_1476

This funding opportunity provides financial support to small businesses that previously received Phase I SBIR grants from NIST, enabling them to further develop their innovative projects into commercially viable products or services.

This funding opportunity supports innovative projects that develop advanced high-voltage direct current technologies to enhance the resilience and sustainability of the U.S. energy grid, targeting domestic entities and collaborations focused on improving power transmission systems.

This grant provides funding for researchers developing innovative electronic, photonic, and magnetic devices to advance technology in areas like communication, healthcare, and energy.

Grant Opportunity: Short-term Teaching Artist Residency Program (Illinois) The Short-term Teaching Artist Residency Program in Illinois supports elementary schools, community centers, and public libraries in engaging teaching artists for short-term residencies. The program prioritizes advancing equity and access in the arts, particularly for underserved audiences such as BIPOC communities, individuals with disabilities, older adults, and those with limited access to the arts. Eligible applicants can request a minimum of $250 and a maximum of $4,500 to cover 75% of residency costs. Additional percentages can be added under specific conditions. Applicants must be tax-exempt organizations or units of government in Illinois, while the selected artists must be based in Illinois. The application deadline is at least eight weeks before the project start date. For more information, visit Short-term Teaching Artist Residency Program.

The City of Wentzville's Facade Improvement Grant Program aims to preserve historic structures and prevent neighborhood deterioration through renovation and restoration efforts. This initiative is a 50-50 matching grant, with individual projects eligible for up to $10,000. While the description does not explicitly state a foundation mission, the program's focus on historic preservation and community revitalization aligns with broader municipal goals of maintaining aesthetic integrity and fostering economic stability within its districts. The program acts as a strategic tool to achieve these city-wide development and preservation objectives. The target beneficiaries of this program are businesses and mixed-use buildings over 30 years old located within the HD-1, HD-2, or HD-3 zoning districts. The impact goals are multifaceted, seeking to boost property development, strengthen both new and existing businesses, and facilitate the rehabilitation and modernization of downtown buildings. By supporting these specific entities, the program intends to create a ripple effect that benefits the entire community through improved infrastructure and a more vibrant commercial landscape. The program's priorities and focuses are clearly articulated: encouraging the preservation of historic structures, preventing general neighborhood deterioration, and promoting renovation and restoration. These priorities are addressed through the specific design of the grants, which require a 50-50 match, indicating a shared investment and commitment to the success of the projects. The emphasis on properties within designated historic and downtown zoning districts underscores the program's strategic focus on areas critical for community identity and economic activity. Expected outcomes include a visible improvement in the physical appearance of buildings within the targeted districts, increased property values, and a more robust local economy driven by strengthened businesses. Measurable results could include the number of facade renovations completed, the total amount of private investment leveraged by the matching grants, and potentially an increase in new business openings or retention rates within the program areas. While a formal "theory of change" is not explicitly stated for the City of Wentzville, the program implicitly operates on the principle that investing in the physical attractiveness and structural integrity of its commercial and historic properties will lead to enhanced community pride, increased economic activity, and sustained neighborhood vitality.

This funding initiative provides financial support to municipalities, Tribal Nations, and eligible organizations in New York State to build publicly controlled broadband networks that deliver affordable internet access to underserved areas.

This program provides funding to Massachusetts-based clean technology startups and academic institutions for projects that advance innovations in areas like high performance buildings, clean transportation, offshore wind, and net zero grid technologies.

This funding opportunity provides financial support for universities, nonprofits, and government entities to develop and operationalize advanced ocean and coastal observing technologies that enhance data collection and environmental monitoring.

This funding opportunity provides financial support to U.S. companies and organizations to boost domestic production capabilities for critical defense materials and technologies, ensuring national security and resilience in the industrial base.

This funding opportunity provides financial support to domestic entities that own or operate coal-fired power plants, enabling them to recommission, modernize, or retrofit their facilities to enhance grid reliability and support energy needs in rural communities.

This funding opportunity seeks innovative research proposals from various entities, including businesses and universities, to develop groundbreaking technologies for national security, focusing on areas like novel materials, quantum computing, and artificial intelligence.

This program provides funding for U.S.-based researchers and institutions to develop innovative technologies and processes that enhance environmental sustainability and resilience while promoting efficient resource use.

This grant provides financial assistance to Maui-based businesses impacted by the recent wildfires, helping them cover essential expenses like rent, utilities, and inventory replacement.

Key aspects of the TSA: Multidisciplinary Collaboration: The success of the project should depend on the unique skills and perspectives of each partner. The application must clearly define the synergistic components that will facilitate and accelerate progress in melanoma in a way that could not be accomplished through independent efforts. The plans for interactions among all PIs and institutions involved must be clearly articulated. Collectively, the members of the research team should represent the appropriate diversity of expertise necessary for addressing the proposed research question. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The following components of the proposed multidisciplinary collaboration are encouraged but not required: It is strongly encouraged that the research team has a least one investigator, key personnel, or consultant who can provide input on the ultimate utility/applicability (short- or long-term) of the anticipated outcome(s) to the melanoma field and/or patient care. The inclusion of an early-career investigator is encouraged. An early-career investigator is defined as an independent, early-career researcher or physician-scientist within 7 years of receiving their first faculty appointment by the time of the full application deadline. Investigators in mentored positions, (e.g., postdoctoral fellows) are not eligible to be named as a PI on a TSA application. The inclusion of a military and/or U.S. Department of Veterans Affairs (VA) investigator is encouraged. A military or VA investigator is defined as an investigator who is active-duty, active reserve, active duty detailed to agencies outside of the Department of Defense (DOD), civilian DOD investigators, or an investigator at a VA research facility. If included as PI on the research team, the military/VA investigator should have a substantial role in the research and should not be included only for access to active-duty military and/or VA populations. Impact: The application must articulate the impact the proposed work, including basic research, will have on melanoma research and/or patient care. Outcomes from this award are expected to expedite the advancement of promising ideas toward clinical applications and/or improve the current state of the science/technology in the melanoma field. The proposed research must relate to at least one of the FY24 MRP Focus Areas in Section II.A.1. Preliminary Data Required: Applications must include preliminary data to support feasibility of the study. However, these data do not necessarily need to be derived from melanoma studies. Any unpublished, preliminary data presented should originate from the laboratory of at least one of the PIs or other member(s) of the research team.

demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the best and brightest in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. Individuals from other disciplines who apply novel concepts to breast cancer are encouraged to submit.The PI is encouraged to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they may not be employees of any organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background and/or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input throughout the research effort and its potential impact for individuals with, or at risk for, breast cancer.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Clinical trials are allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 Era of Hope Scholar Award should not exceed $3.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $5.4M to fund approximately one Era of Hope Scholar Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity provides financial support to small businesses engaged in innovative research and development projects that have the potential for commercialization and significant societal impact.

This funding opportunity provides financial assistance to bioscience start-ups, early-stage businesses, and academic institutions in Connecticut to help accelerate the commercialization of innovative bioscience breakthroughs.